All reports
Pharmaceutical
Biosimilars & Generics
Biosimilar-First and Step Therapy: Payer Strategies
Code: NSC/PHRM/0018Published Apr 01, 2026Data window: 6 months
About this report
US PBM biosimilar-first adoption, formularies, IRA negotiation and the European market.
Humans at the core of the analysis
Partner specialist firms, independent domain experts and our in-house analyst team: every report is written and reviewed by humans who cross-check signals, verify sources and prioritise what matters.
Key insights
Request the sample to discover the report's key insights.
Table of contents
The detailed table of contents is shared with the free sample.